Additional Consequences of Termination. Upon the expiration or termination (including cancellation) of the PO or the Agreement for any reason each party will immediately stop using, and destroy or return to the other party, all items that contain any Confidential Information belonging to the other party, except Buyer may retain one copy of any Confidential Information necessary for the purpose of supporting the Equipment. Upon termination of the PO or the Agreement, Supplier will: (a) promptly terminate all work under the Agreement; (b) upon instruction from Buyer, transfer title and deliver to Buyer the Equipment free and clear of liens, claims and encumbrances; (c) verify and settle any claims by subcontractors for actual costs incurred directly as a result of the termination and ensure the recovery of materials in subcontractors’ possession; (d) take actions reasonably necessary to protect property in Supplier’s possession in which Xxxxx has an interest until disposal instruction from Buyer has been received; and (e) upon Buyer’s request, cooperate with Buyer in transferring the production of Equipment to a different supplier. Notwithstanding any other provision, Buyer will have no obligation for and will not be required to pay Supplier, directly or on account of claims by Supplier’s subcontractors, for loss of anticipated profit, unabsorbed overhead, interest on claims, product development and engineering costs, tooling, facilities and equipment rearrangement costs or rental, unamortized capital or depreciation costs, finished goods, work-in-process or raw materials that Supplier fabricates or procures, or general administrative burden charges from termination of the PO or the Agreement, except as otherwise expressly agreed in writing by Xxxxx. Supplier will furnish to Buyer, within one month after the date of termination, its termination claim, which will consist exclusively of the items of Buyer’s obligation to Supplier that are expressly permitted by this Section and GTCs. Buyer may audit Supplier’s records before or after payment to verify amounts requested in Supplier’s termination claim. Buyer will have no obligation for payment to Supplier under this Section if Buyer terminates the PO or the Agreement or any portion thereof because of a default or breach by Supplier.
Additional Consequences of Termination. Upon termination of this Agreement in its entirety by Company pursuant to Section 14.2 (Material Breach) or by Licensee pursuant to Section 14.3(a) (Convenience), or in the case of Sections 14.5(b), 14.5(c), 14.5(f), 14.5(g), 14.5(j), 14.5(k) and 14.5(l) upon any termination of this Agreement, the following terms and conditions will apply:
Additional Consequences of Termination. Upon any termination pursuant to this Article 20, Contractor shall have no further liability for payment of unaccrued liquidated damages for failure to meet Schedule pursuant to Article 22, nor liquidated damages for failure to meet the Performance Guarantees pursuant to Article 22. Owner may at its option elect to (a) take possession of the Work performed to date, materials or equipment remaining at the Site, and (b) succeed to the interests of Contractor in any or all subcontracts entered into by Contractor with respect to the Project, and shall be required to compensate such Subcontractors only for compensation becoming due and payable to such parties under the terms of their Subcontracts with Contractor from and after the date Owner elects to succeed to the interests of Contractor in such Subcontracts.
Additional Consequences of Termination. In addition to the foregoing, promptly upon the termination of this Agreement in its entirety or with respect to one or more countries by AstraZeneca pursuant to Section 17.3, 17.4, 17.5, or 18.4 or by Neoprobe pursuant to Section 17.2:
Additional Consequences of Termination. If the Employee ceases to be an employee of the Company, Employee shall immediately return all Confidential Information as set forth above and any other Company property in his possession or control, such as keys, Company employee credit cards, employee pass, equipment and the Company provided vehicle. Employee further agrees that at the Company's request and subject to reasonable notice, Employee will cooperate at any time in the future with and make himself available to the Company to testify as a witness in any legal proceedings and/or assist in any investigation, without need for a subpoena. Such cooperation will be without cost to the Company except for reimbursement of all reasonable and necessary out-of-pocket expenses.
Additional Consequences of Termination. (a) If Licensee terminates this Agreement pursuant to Section 15.5 prior to the grant of first Regulatory Approval in the United States for the Licensed Product and during an ongoing Phase II Study or Phase III Study, then, in addition to the activities described in Section 15.8, Licensee shall be responsible to pay Anacor all amounts required to complete the ongoing Phase II Study or Phase III Study up to [***]; provided, that no such payment will be due in the event of a termination described in Section 15.9(b) below. Such costs will be reimbursed through quarterly payments to be made by Licensee within thirty (30) days following receipt of detailed quarterly invoices to be issued by Anacor.
Additional Consequences of Termination. (i) In addition to the consequences set forth in Section 13.6(a), upon termination by Novavax pursuant to Section 13.3 or Section 13.5, Takeda shall grant to Novavax a non-exclusive, non-transferable, fully-paid, perpetual license or sublicense, as applicable, with the right to grant sublicenses (through multiple tiers) under the Takeda Technology and Takeda’s right in the Joint Technology solely for the purposes of Exploiting the Vaccine anywhere in the world.
Additional Consequences of Termination. In addition to the consequences set forth in the Agreement, immediately upon termination of this Agreement or a particular Service Order(s) Subscriber shall destroy any and all copies of the Collector Software in its possession or control and the parties’ rights and obligations under Sections 3 and 4 of this Addendum shall survive.
Additional Consequences of Termination. Upon any termination of this Agreement, with respect to one or more regions or countries in the Territory:
Additional Consequences of Termination. In addition to the foregoing, promptly upon the termination of this Agreement in its entirety or with respect to one or more countries by AstraZeneca pursuant to Section 17.3, 17.4, 17.5, or 18.4 or by Neoprobe pursuant to Section 17.2: Page 52 of 63 9 December 2011 AZ./.Neoprobe Confidential Treatment – Asterisked material has been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.
